Literature DB >> 25907749

The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model.

Ingrid Morales1, Alberto Sanchez2, Clara Rodriguez-Sabate3, Manuel Rodriguez4.   

Abstract

Available evidence increasingly suggests that the degeneration of dopamine neurons in Parkinson's disease starts in the striatal axons and synaptic terminals. A selective procedure is described here to study the mechanisms involved in the striatal denervation of dopaminergic terminals. This procedure can also be used to analyze mechanisms involved in the dopaminergic re-innervation of the striatum, and the role of astrocytes and microglia in both processes. Adult Sprague-Dawley rats were injected in the lateral ventricles with increasing doses of 6-hydroxydopamine (12-50 μg), which generated a dose-dependent loss of dopaminergic synapses and axons in the striatum, followed by an axonal sprouting (weeks later) and by a progressive recovery of striatal dopaminergic synapses (months later). Both the degeneration and regeneration of the dopaminergic terminals were accompanied by astrogliosis. Because the experimental manipulations did not induce unspecific damage in the striatal tissue, this method could be particularly suitable to study the basic mechanisms involved in the distal degeneration and regeneration of dopaminergic nigrostriatal neurons, and the possible role of astrocytes and microglia in the dynamics of both processes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6OHDA; Astrocyte; Dying-back degeneration; Lateral ventricle; Microglia; Parkinson's disease; Striatum

Mesh:

Substances:

Year:  2015        PMID: 25907749     DOI: 10.1016/j.bbr.2015.04.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

Review 1.  Role of astrocyte-synapse interactions in CNS disorders.

Authors:  Elena Blanco-Suárez; Alison L M Caldwell; Nicola J Allen
Journal:  J Physiol       Date:  2016-08-08       Impact factor: 5.182

Review 2.  Aging of perennial cells and organ parts according to the programmed aging paradigm.

Authors:  Giacinto Libertini; Nicola Ferrara
Journal:  Age (Dordr)       Date:  2016-03-08

3.  Ion mobility mass spectrometry enhances low-abundance species detection in untargeted lipidomics.

Authors:  Abdul Basit; Silvia Pontis; Daniele Piomelli; Andrea Armirotti
Journal:  Metabolomics       Date:  2016-02-08       Impact factor: 4.290

4.  Synaptic aging disrupts synaptic morphology and function in cerebellar Purkinje cells.

Authors:  Wen-Juan Fan; Ming-Chao Yan; Lai Wang; Yi-Zheng Sun; Jin-Bo Deng; Jie-Xin Deng
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

Review 5.  Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.

Authors:  Jessika C Bridi; Frank Hirth
Journal:  Front Neurosci       Date:  2018-02-19       Impact factor: 4.677

6.  Reduced vocal variability in a zebra finch model of dopamine depletion: implications for Parkinson disease.

Authors:  Julie E Miller; George W Hafzalla; Zachary D Burkett; Cynthia M Fox; Stephanie A White
Journal:  Physiol Rep       Date:  2015-11

7.  Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.

Authors:  Ingrid Morales; Alberto Sanchez; Clara Rodriguez-Sabate; Manuel Rodriguez
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

Review 8.  The where, what, and when of membrane protein degradation in neurons.

Authors:  Eugene Jennifer Jin; Ferdi Ridvan Kiral; Peter Robin Hiesinger
Journal:  Dev Neurobiol       Date:  2017-09-19       Impact factor: 3.964

9.  Live Observation of Two Parallel Membrane Degradation Pathways at Axon Terminals.

Authors:  Eugene Jennifer Jin; Ferdi Ridvan Kiral; Mehmet Neset Ozel; Lara Sophie Burchardt; Marc Osterland; Daniel Epstein; Heike Wolfenberg; Steffen Prohaska; Peter Robin Hiesinger
Journal:  Curr Biol       Date:  2018-03-15       Impact factor: 10.834

10.  Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson's disease.

Authors:  Amy K Reeve; John P Grady; Eve M Cosgrave; Emma Bennison; Chun Chen; Philippa D Hepplewhite; Christopher M Morris
Journal:  NPJ Parkinsons Dis       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.